Michael Kauffman

CEO

CEO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	Karyopharm Therapeutics Inc. (KPTI)	M.D., Ph.D.	$474,375	—	$832,832	$1,507,217	$237,188	$17,977	$3,069,589
2020	Karyopharm Therapeutics Inc. (KPTI)	M.D., Ph.D. Chief Executive Officer	$625,624	—	$1,029,886	$1,920,899	$348,750	$11,880	$3,937,039
2019	Karyopharm Therapeutics Inc. (KPTI)	M.D., Ph.D. Chief Executive Officer	$566,500	—	$803,112	$1,486,339	$363,693	$11,860	$3,231,504
2018	Karyopharm Therapeutics Inc. (KPTI)	M.D., Ph.D. Chief Executive Officer	$550,000	—	—	$1,444,660	$268,625	$11,660	$2,274,945

Executive changes

Resigned member of the Company's Board of Directors at Karyopharm Therapeutics Inc. (KPTI)
2022-03-22
Resigned Senior Clinical Advisor at Karyopharm Therapeutics Inc. (KPTI)
2022-05-31

Earnings-call appearances

Karyopharm Therapeutics Inc. Q1 FY2021 Earnings Call
Karyopharm Therapeutics Inc. (KPTI)

2021-05-03
Karyopharm Therapeutics Inc. Q4 FY2020 Earnings Call
Karyopharm Therapeutics Inc. (KPTI)

2021-01-11
Karyopharm Therapeutics Inc. Q3 FY2020 Earnings Call
Karyopharm Therapeutics Inc. (KPTI)

2020-11-02
Karyopharm Therapeutics Inc. Q2 FY2020 Earnings Call
Karyopharm Therapeutics Inc. (KPTI)

2020-07-14
Karyopharm Therapeutics Inc. Q1 FY2020 Earnings Call
Karyopharm Therapeutics Inc. (KPTI)

2020-05-05